February 18, 2011
DSM announces receipt of final competition clearance for acquisition of Martek
Press Release
Royal DSM N.V. has received the unconditional clearance of the Counsel of the National Competition Commission in Spain for its previously announced tender offer for all outstanding shares of common stock of Martek Biosciences Corporation at a price of US$31.50 per share.
This was the final clearance needed under applicable antitrust and competition laws and this condition of the offer is thus completely satisfied.
The offer remains subject to the satisfaction of certain other conditions. The offer is scheduled to expire at 5:00 p.m. (New York City time) on Friday (Feb 18), unless the offer is extended.
